Literature DB >> 27489069

Renal amyloidosis in leprosy, an infrequent cause of nephrotic syndrome in Europe.

Noelia Sanz-Martín1, Kelly Del Rocío Samillán-Sosa1, Julio De Miguel2, Patricia Martínez-Miguel1.   

Abstract

Leprosy is a chronic infectious disease caused by Mycobacterium leprae The main clinical manifestations involve the skin and the peripheral nervous system. Several types of nephropathy have been described in leprosy. One frequent form of renal involvement is amyloidosis, especially in patients with lepromatous leprosy. In these patients, end-stage renal disease is an important contributor to morbidity and mortality. Here, we present the case of a patient with nephrotic syndrome caused by secondary amyloidosis, chronic peripheral neuropathy and a history of leprosy. The patient was correctly treated in her youth, which is the best way to avoid renal pathology, but she developed a nephrotic syndrome years later. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27489069      PMCID: PMC4986063          DOI: 10.1136/bcr-2016-216038

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Renal lesions in leprosy: a retrospective study of 199 autopsies.

Authors:  E E Nakayama; S Ura; R N Fleury; V Soares
Journal:  Am J Kidney Dis       Date:  2001-07       Impact factor: 8.860

2.  Renal involvement in leprosy: retrospective analysis of 461 cases in Brazil.

Authors:  Geraldo Bezerra da Silva Júnior; Elizabeth De Francesco Daher
Journal:  Braz J Infect Dis       Date:  2006-04       Impact factor: 1.949

3.  Global leprosy update, 2013; reducing disease burden.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2014-09-05

4.  Immune complexes in glomeruli of patients with leprosy.

Authors:  T Shwe
Journal:  Lepr Rev       Date:  1971-12       Impact factor: 0.537

Review 5.  Leprosy.

Authors:  Warwick J Britton; Diana N J Lockwood
Journal:  Lancet       Date:  2004-04-10       Impact factor: 79.321

6.  Renal lesions and other major findings in necropsies of 133 patients with leprosy.

Authors:  A Date; S Harihar; S E Jeyavarthini
Journal:  Int J Lepr Other Mycobact Dis       Date:  1985-09

7.  Leprosy-associated renal disease: case report and review of the literature.

Authors:  N Ahsan; D E Wheeler; B F Palmer
Journal:  J Am Soc Nephrol       Date:  1995-02       Impact factor: 10.121

8.  Acute renal failure in leprosy.

Authors:  P C Singhal; K S Chugh; S Kaur; A K Malik
Journal:  Int J Lepr Other Mycobact Dis       Date:  1977 Apr-Jun

9.  Glomerulonephritis in leprosy.

Authors:  W L Ng; D M Scollard; A Hua
Journal:  Am J Clin Pathol       Date:  1981-09       Impact factor: 2.493

Review 10.  Leprosy and glomerulonephritis: case report and review of the literature.

Authors:  I D Weiner; A D Northcutt
Journal:  Am J Kidney Dis       Date:  1989-05       Impact factor: 8.860

View more
  3 in total

1.  An outbreak of tuberculosis due to Mycobacterium bovis infection in a pack of English Foxhounds (2016-2017).

Authors:  Conor O'Halloran; Jayne C Hope; Melanie Dobromylskyj; Paul Burr; Kieran McDonald; Shelley Rhodes; Tony Roberts; Richard Dampney; Ricardo De la Rua-Domenech; Nicholas Robinson; Danielle A Gunn-Moore
Journal:  Transbound Emerg Dis       Date:  2018-07-30       Impact factor: 5.005

2.  Serum Interleukin 6 Level and Nutrition Status as Potential Predictors of Clinical Leprosy Development Among Household Contacts in Endemic Areas.

Authors:  Salma Oktaria; Fatih Anfasa; Sri Linuwih Menaldi; Kusmarinah Bramono; Tamar E C Nijsten; Hok Bing Thio
Journal:  Open Forum Infect Dis       Date:  2022-02-02       Impact factor: 3.835

3.  Cardiovascular disease risk factors and markers of oxidative stress and DNA damage in leprosy patients in Southern Nigeria.

Authors:  Iya Eze Bassey; Inyeneobong Ernest Inyang; Uwem Okon Akpan; Idongesit Kokoabasi Paul Isong; Bassey Edward Icha; Victoria Micheal Ayawan; Racheal Ekanem Peter; Hopefaith Adode Itita; Prince Ukam Odumusor; Eyoanwan Graziani Ekanem; Okon Ekwerre Essien
Journal:  PLoS Negl Trop Dis       Date:  2020-10-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.